BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 33360905)

  • 1. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
    Tian H; Zhang M; Jin G; Jiang Y; Luan Y
    J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
    Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
    J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
    Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
    Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic nanoplatform with H
    Fu LH; Wu XY; He J; Qi C; Lin J; Huang P
    Acta Biomater; 2023 May; 162():44-56. PubMed ID: 36934891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-Free H
    Yang T; Zhou M; Gao M; Qin W; Wang Q; Peng H; Yao W; Qiao L; He X
    Small; 2023 Feb; 19(7):e2205692. PubMed ID: 36494182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
    Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
    Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prussian Blue-Derived Nanoplatform for In Situ Amplified Photothermal/Chemodynamic/Starvation Therapy.
    Liang J; Sun Y; Wang K; Zhang Y; Guo L; Bao Z; Wang D; Xu H; Zheng J; Yuan Y
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):18191-18204. PubMed ID: 36975190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intelligent Nanoplatform with Multi Therapeutic Modalities for Synergistic Cancer Therapy.
    Shao L; Hu T; Fan X; Wu X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    ACS Appl Mater Interfaces; 2022 Mar; 14(11):13122-13135. PubMed ID: 35286061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multifunctional Nanoplatform Based on Fenton-like and Russell Reactions of Cu, Mn Bimetallic Ions Synergistically Enhanced ROS Stress for Improved Chemodynamic Therapy.
    Ma W; Zhang H; Li S; Wang Z; Wu X; Yan R; Geng F; Mu W; Jin Y
    ACS Biomater Sci Eng; 2022 Mar; 8(3):1354-1366. PubMed ID: 35230802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.
    Chen Q; Zhou J; Chen Z; Luo Q; Xu J; Song G
    ACS Appl Mater Interfaces; 2019 Aug; 11(34):30551-30565. PubMed ID: 31397998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
    Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
    ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H
    Zhao Y; Wu Y; Xu Q; Liu Y; Song Z; Han H
    J Nanobiotechnology; 2024 Mar; 22(1):117. PubMed ID: 38493145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper peroxide coated upconversion nanoparticle modified with glucose oxidase for H
    Hong Y; Tao Q; Liu YY; Wang Z; Wang H; Sun L
    Dalton Trans; 2022 Aug; 51(30):11325-11334. PubMed ID: 35838196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A self-amplified nanocatalytic system for achieving "1 + 1 + 1 > 3" chemodynamic therapy on triple negative breast cancer.
    Zhou L; Chen J; Sun Y; Chai K; Zhu Z; Wang C; Chen M; Han W; Hu X; Li R; Yao T; Li H; Dong C; Shi S
    J Nanobiotechnology; 2021 Sep; 19(1):261. PubMed ID: 34481495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Pot Rapid Synthesis of Cu
    Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H
    Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
    Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
    Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
    J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface curvature-induced oriented assembly of sushi-like Janus therapeutic nanoplatform for combined chemodynamic therapy.
    Ma Y; Liu M; Hou M; Kou Y; Wang W; Zhao T; Li X
    J Nanobiotechnology; 2023 Nov; 21(1):425. PubMed ID: 37968644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H
    Yan Y; Han R; Zhang H; Song P; Wei X; Hou Y; Yu J; Tang K
    Colloids Surf B Biointerfaces; 2023 Jan; 221():112997. PubMed ID: 36334518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.